Suneth (w’imyaka 45) yaje kwa muganga wanjye kuwa gatatu ushize mu rujijo. Suneth ni umuyobozi wa banki utanywa inzoga na gato kandi akora akazi ke neza. Ariko, mu isuzuma rye rya buri mwaka ry’ubuvuzi, imisemburo ye y’umwijima (AST/ALT) yari iri hejuru cyane, kandi isuzuma rya ultrasound mu nda ryagaragaje ko yari afite umwijima urimo ibinure byinshi.
Suneth yabajije mu ijwi ry'ubwoba ati: "Muganga Priya, sinigeze nnywa inzoga na gato mu buzima bwanjye. Ni gute umwijima wanjye waba wuzuye ibinure kandi ukagira indwara y'umwijima? Sinshobora no kwiyumvisha ibi."
Nasobanuriye Suneth mu buryo bworoheje. "Suneth, si wowe wenyine, ahubwo n'abantu benshi bo muri Sri Lanka batekereza ko indwara y'umwijima ibaho gusa iyo unyoye inzoga. Ariko n'abantu batanywa inzoga bashobora kugira ibinure mu mwijima wabo. Mu buvuzi, iyi ndwara tuyita indwara y'umwijima idafite inzoga (NAFLD) . Icyiciro gikomeye cyane kandi cy'ububyimbirwe bw'indwara ni indwara idafite inzoga yitwa Steatohepatitis (NASH) . Uyu munsi, reka tubiganireho mu magambo make."
TDEE Calculator
Calculate the number of calories needed per day to lose, gain or maintain weight
🚨 Indwara zidasanzwe zisaba ubuvuzi bwihuse
Nubwo NASH ishobora kutagira ibimenyetso mu ntangiriro, ibimenyetso bikurikira bishobora kugaragara iyo igeze ku kunanirwa gukomeye k'umwijima. Muri ibyo bihe, ni ngombwa ko umuntu ajya mu bitaro byihutirwa:
- Ibara ry'umuhondo ku ruhu n'umweru by'amaso (jaundice).
- Ascites ni indwara ituma inda ibyimba kandi ikabyimba bitewe n’amazi menshi asanzwe yirundanya mu nda yo hasi no mu kibuno.
- Kuruka amaraso atukura cyangwa kwiyahura n'umukara, kwituma mu buryo butunguranye (ikimenyetso cyo kuva amaraso imbere mu mubiri).
- Kumva kenshi umuntu asinziriye cyane, atabasha kumva icyo avuga, cyangwa urujijo rukomeye (Hepatic Encephalopathy).
- Gukomereka cyangwa kuva amaraso byoroshye ku ruhu.
Ni irihe tandukaniro riri hagati ya NAFLD na NASH?
Indwara y'umwijima w'ibinure ku bantu batanywa inzoga ishobora kugabanywamo ibice bibiri by'ingenzi:
1. Umwijima w'ibinure byoroshye (NAFLD): Muri iki kibazo, nubwo ibinure biba biri mu mwijima, nta kwangirika cyangwa kubyimba kw'uturemangingo tw'umwijima bibaho. Ibi akenshi ntibitera ingorane zikomeye.
2. Steatohepatite idakoreshejwe inzoga (NASH): Iyi ni indwara ikomeye cyane. Muri iyi ndwara, ibinure byinshi mu mwijima bituma uturemangingo tw'umwijima tubyimba kandi tukangirika. Ibi bitera inzira yitwa fibrosis, itera inkovu mu mwijima. Iyo itavuwe, ibi bishobora gutera cirrhose, indwara ituma umwijima ukomera burundu ugahagarara gukora.
Impamvu nyamukuru n'ibintu bishobora gutera NASH
Ibibazo bya metabolisme mu mubiri bitera ibinure byiyongera bitari ngombwa mu mwijima. Ibintu by'ingenzi bigira ingaruka kuri ibi ni ibi bikurikira:
- Umubyibuho ukabije wo hagati: Ibinure byinshi byirundanyije hafi y'inda.
- Diyabete yo mu bwoko bwa 2: Kudashobora kugenzura neza urugero rw'isukari mu maraso.
- Ubudahangarwa bwa insuline: Kudashobora k'uturemangingo gukoresha imisemburo ya insuline neza.
- Ibinure byinshi mu maraso: Kolesteroli na triglyceride byiyongera.
- Ingeso mbi zo kurya: Kunywa kenshi ibinyobwa biryoshye by’ubukorano, ibiryo byihuse, n’ibiryo birimo ibinure byinshi.
Uburyo bwo gusuzuma indwara
Abaganga bakora ibizamini bikurikira kugira ngo barebe niba NASH ihari:
- Gupima amaraso (Ibipimo by'imikorere y'umwijima - LFT): Gupima urugero rwa enzymes z'umwijima (ALT, AST).
- Gupima umwijima mu buryo bwa Ultrasound: Bigaragaza neza niba hari ibinure mu mwijima.
- FibroScan: Ikizamini cyoroshye cyo gupima inkovu z'umwijima (fibrosis) n'ubukana bwawo.
- Isuzuma ry'umwijima: Ikizamini gifata agace gato k'umwijima kugira ngo cyemeze neza indwara.
Ibisubizo byo kugenzura NASH no kurinda umwijima
Nubwo imiti yihariye yatanzwe ku ndwara ya NASH ari mike, guhindura imibereho bishobora gufasha mu kugabanya burundu ibinure mu mwijima:
1. Kugabanya ibiro (igisubizo nyamukuru):
Mu kugabanya buhoro buhoro hagati ya 7% na 10% by'ibiro byawe ubu, ushobora gukuraho burundu ibinure n'ububyimba mu mwijima.
No comments yet. Be the first to share your question or experience below.